Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


08.08.2022

1 Am J Cardiol
1 Cardiovasc Res
2 Circ Heart Fail
1 Circ Res
2 Clin Cardiol
3 Eur Heart J
9 Eur J Heart Fail
2 Heart
3 Int J Cardiol
2 J Am Coll Cardiol
1 J Card Fail
1 J Cardiol
1 J Cardiovasc Pharmacol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. CORRA U, Piepoli MF, Giordano A, Doni F, et al
    Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population).
    Am J Cardiol. 2022 Jul 29. pii: S0002-9149(22)00707.
    PubMed         Abstract available


    Cardiovasc Res

  2. SAVARESE G, Butler J, Lund LH, Bhatt DL, et al
    Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms.
    Cardiovasc Res. 2022;118:2231-2252.
    PubMed         Abstract available


    Circ Heart Fail

  3. MIRZAI S, Eck BL, Chen PH, Estep JD, et al
    Current Approach to the Diagnosis of Sarcopenia in Heart Failure: A Narrative Review on the Role of Clinical and Imaging Assessments.
    Circ Heart Fail. 2022 Aug 4:101161CIRCHEARTFAILURE121009322.
    PubMed         Abstract available

  4. BEDROUNI W, Sharma A, Pitt B, Lam CSP, et al
    Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction.
    Circ Heart Fail. 2022 Aug 4:101161CIRCHEARTFAILURE121009295.
    PubMed        


    Circ Res


  5. Correction to: Heart Failure with Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;131:e100.
    PubMed        


    Clin Cardiol

  6. AHLGRIM C, Seiler F, Birkner P, Schoechlin S, et al
    Clinically unrecognized plasma volume expansion predicts long-term all-cause-mortality in chronic heart failure.
    Clin Cardiol. 2022 Aug 3. doi: 10.1002/clc.23893.
    PubMed         Abstract available

  7. SHANG W, Zhang Y, Han D
    Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2022 Aug 2. doi: 10.1002/clc.23889.
    PubMed         Abstract available


    Eur Heart J

  8. TRIBOUILLOY C, Bohbot Y, Kubala M, Ruschitzka F, et al
    Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2022 May 2. pii: 6576528. doi: 10.1093.
    PubMed         Abstract available

  9. BAUERSACHS J, Olsson KM
    Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
    Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.
    PubMed        

  10. DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
    Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
    Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
    PubMed         Abstract available


    Eur J Heart Fail

  11. KRISTENSEN SL, Gustafsson F
    Advanced Heart Failure: time to screen?
    Eur J Heart Fail. 2022 Jul 18. doi: 10.1002/ejhf.2624.
    PubMed        

  12. DANDEL M, Hetzer R
    Particular Challenges in the Use of Pulmonary Vasodilating Therapy for Patients with Pulmonary Hypertension Secondary to Left Heart Diseases.
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2622.
    PubMed        

  13. BORIANI G, Vitolo M, Imberti JF
    Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction.
    Eur J Heart Fail. 2022 Jul 29. doi: 10.1002/ejhf.2642.
    PubMed        

  14. ANTOHI LE, Adamo M, Chioncel O
    Long-term Survival after Acute Heart Failure Hospitalization; From Observation to Collaborative Interventions.
    Eur J Heart Fail. 2022 Aug 2. doi: 10.1002/ejhf.2645.
    PubMed        

  15. GENTILE F, Passino C, Emdin M, Giannoni A, et al
    Baroreflex activation therapy in heart failure: targeting the right patient.
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2627.
    PubMed        

  16. JANSE RJ, Fu EL, Dahlstrom U, Benson L, et al
    Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence.
    Eur J Heart Fail. 2022 Jul 18. doi: 10.1002/ejhf.2620.
    PubMed         Abstract available

  17. REDDY YNV, Sundaram V
    Spironolactone, fibrosis and heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2626.
    PubMed        

  18. CHUNAWALA ZS, Qamar A, Arora S, Pandey A, et al
    Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: The ARIC study community surveillance.
    Eur J Heart Fail. 2022 Jul 18. doi: 10.1002/ejhf.2617.
    PubMed         Abstract available

  19. KOZHUHAROV N, Martin J, Wussler D, Lopez-Ayala P, et al
    Clinical Effect of Obesity on NT-proBNP Cut-off Concentrations for the Diagnosis of Acute Heart Failure.
    Eur J Heart Fail. 2022 Jul 18. doi: 10.1002/ejhf.2618.
    PubMed         Abstract available


    Heart

  20. TAN ESJ, Oon YY, Chan SP, Liew OW, et al
    Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320707. doi: 10.1136/heartjnl-2021-320707
    PubMed         Abstract available

  21. LI J, Zhen Z, Huang P, Dong YG, et al
    Salt restriction and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Heart. 2022 Jul 18. pii: heartjnl-2022-321167. doi: 10.1136/heartjnl-2022-321167
    PubMed         Abstract available


    Int J Cardiol

  22. TANG SS, Wang XJ, Tang CK
    The authors' reply to the letter "CA125 a cause or an effect in heart failure?"
    Int J Cardiol. 2022 Jul 31. pii: S0167-5273(22)01114.
    PubMed        

  23. AIMO A, Lupon J, Spitaleri G, Domingo M, et al
    Global warming, renal function and heart failure over 20years.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01113.
    PubMed         Abstract available

  24. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    PubMed         Abstract available


    J Am Coll Cardiol

  25. YE F, Wang X, Wu S, Ma S, et al
    Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    J Am Coll Cardiol. 2022;80:584-594.
    PubMed         Abstract available

  26. BOCCHI EA, Lima IGCV
    The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
    J Am Coll Cardiol. 2022;80:595-597.
    PubMed        


    J Card Fail

  27. RAO VN, Kaltenbach LA, Granger BB, Fonarow GC, et al
    The Association of Digital Health Application Use with Heart Failure Care and Outcomes: Insights from CONNECT-HF.
    J Card Fail. 2022 Jul 26. pii: S1071-9164(22)00646.
    PubMed         Abstract available


    J Cardiol

  28. MAEKAWA Y, Takamisawa I, Takano H, Takayama M, et al
    Percutaneous transluminal septal myocardial ablation: past, present, and future.
    J Cardiol. 2022;80:211-217.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  29. LI S, Huang Y, Li T, Zhu X, et al
    Glucocorticoids promote Na+ excretion in the renal epithelia of heart failure rats by suppressing transporter proteins involved in acute sodium loading.
    J Cardiovasc Pharmacol. 2022 Jun 13. pii: 00005344-990000000-00064.
    PubMed         Abstract available


    PLoS One

  30. AMIROVA A, Lucas R, Cowie MR, Haddad M, et al
    Perceived barriers and enablers influencing physical activity in heart failure: A qualitative one-to-one interview study.
    PLoS One. 2022;17:e0271743.
    PubMed         Abstract available

  31. ALCARAZ A, Pichon-Riviere A, Rojas-Roque C, Gonzalez JM, et al
    Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina.
    PLoS One. 2022;17:e0271519.
    PubMed         Abstract available

  32. GUO YG, Zhang Y, Liu WL
    The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
    PLoS One. 2022;17:e0271985.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: